pubmed.ncbi.nlm.nih.gov

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin - PubMed

  • ️Mon Jan 01 2001

. 2001 Nov 9;294(5545):1307-13.

doi: 10.1126/science.1063866. Epub 2001 Oct 4.

Affiliations

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin

S K Shenoy et al. Science. 2001.

Abstract

Although trafficking and degradation of several membrane proteins are regulated by ubiquitination catalyzed by E3 ubiquitin ligases, there has been little evidence connecting ubiquitination with regulation of mammalian G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptor (GPCR) function. Agonist stimulation of endogenous or transfected beta2-adrenergic receptors (beta2ARs) led to rapid ubiquitination of both the receptors and the receptor regulatory protein, beta-arrestin. Moreover, proteasome inhibitors reduced receptor internalization and degradation, thus implicating a role for the ubiquitination machinery in the trafficking of the beta2AR. Receptor ubiquitination required beta-arrestin, which bound to the E3 ubiquitin ligase Mdm2. Abrogation of beta-arrestin ubiquitination, either by expression in Mdm2-null cells or by dominant-negative forms of Mdm2 lacking E3 ligase activity, inhibited receptor internalization with marginal effects on receptor degradation. However, a beta2AR mutant lacking lysine residues, which was not ubiquitinated, was internalized normally but was degraded ineffectively. These findings delineate an adapter role of beta-arrestin in mediating the ubiquitination of the beta2AR and indicate that ubiquitination of the receptor and of beta-arrestin have distinct and obligatory roles in the trafficking and degradation of this prototypic GPCR.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances